Story perspectives

China Greenlights First Brain Chip for Paralysis Treatment

3/21/2026

27 3

Summary

Story summary

China approved the first commercial brain chip, the NEO implant, developed by Neuracle Medical Technology, to assist individuals with paralysis.
The National Medical Products Administration (NMPA) authorized the implant after 18 months of safety testing.
Other companies, including Neuralink, face delays in regulatory approval.
China's push for brain-computer interface technology is part of a broader strategy to lead in this field, as competition with the United States intensifies.

1 of 1

Story summary

China approved the first commercial brain chip, the NEO implant, developed by Neuracle Medical Technology, to assist individuals with paralysis.
The National Medical Products Administration (NMPA) authorized the implant after 18 months of safety testing.
Other companies, including Neuralink, face delays in regulatory approval.
China's push for brain-computer interface technology is part of a broader strategy to lead in this field, as competition with the United States intensifies.